These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 24359128)

  • 1. Structural brain changes associated with antipsychotic treatment in schizophrenia as revealed by voxel-based morphometric MRI: an activation likelihood estimation meta-analysis.
    Torres US; Portela-Oliveira E; Borgwardt S; Busatto GF
    BMC Psychiatry; 2013 Dec; 13():342. PubMed ID: 24359128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illness.
    Torres US; Duran FL; Schaufelberger MS; Crippa JA; Louzã MR; Sallet PC; Kanegusuku CY; Elkis H; Gattaz WF; Bassitt DP; Zuardi AW; Hallak JE; Leite CC; Castro CC; Santos AC; Murray RM; Busatto GF
    Neuroimage Clin; 2016; 12():1-15. PubMed ID: 27354958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gray matter volume changes following antipsychotic therapy in first-episode schizophrenia patients: A longitudinal voxel-based morphometric study.
    Guo F; Zhu YQ; Li C; Wang XR; Wang HN; Liu WM; Wang LX; Tian P; Kang XW; Cui LB; Xi YB; Yin H
    J Psychiatr Res; 2019 Sep; 116():126-132. PubMed ID: 31233895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia: an activation likelihood estimation meta-analysis of illness progression.
    Chan RC; Di X; McAlonan GM; Gong QY
    Schizophr Bull; 2011 Jan; 37(1):177-88. PubMed ID: 19633214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment.
    McClure RK; Phillips I; Jazayerli R; Barnett A; Coppola R; Weinberger DR
    Psychiatry Res; 2006 Dec; 148(2-3):121-32. PubMed ID: 17097276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain structural changes associated with chronicity and antipsychotic treatment in schizophrenia.
    Tomelleri L; Jogia J; Perlini C; Bellani M; Ferro A; Rambaldelli G; Tansella M; Frangou S; Brambilla P;
    Eur Neuropsychopharmacol; 2009 Dec; 19(12):835-40. PubMed ID: 19717283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies.
    Fusar-Poli P; Smieskova R; Kempton MJ; Ho BC; Andreasen NC; Borgwardt S
    Neurosci Biobehav Rev; 2013 Sep; 37(8):1680-91. PubMed ID: 23769814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings.
    Navari S; Dazzan P
    Psychol Med; 2009 Nov; 39(11):1763-77. PubMed ID: 19338710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis.
    Glahn DC; Laird AR; Ellison-Wright I; Thelen SM; Robinson JL; Lancaster JL; Bullmore E; Fox PT
    Biol Psychiatry; 2008 Nov; 64(9):774-81. PubMed ID: 18486104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional Abnormality of Grey Matter in Schizophrenia: Effect from the Illness or Treatment?
    Yue Y; Kong L; Wang J; Li C; Tan L; Su H; Xu Y
    PLoS One; 2016; 11(1):e0147204. PubMed ID: 26789520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal voxel-based meta-analysis of structural and functional magnetic resonance imaging studies in those at elevated genetic risk of developing schizophrenia.
    Cooper D; Barker V; Radua J; Fusar-Poli P; Lawrie SM
    Psychiatry Res; 2014 Jan; 221(1):69-77. PubMed ID: 24239093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gray matter atrophy in narcolepsy: An activation likelihood estimation meta-analysis.
    Weng HH; Chen CF; Tsai YH; Wu CY; Lee M; Lin YC; Yang CT; Tsai YH; Yang CY
    Neurosci Biobehav Rev; 2015 Dec; 59():53-63. PubMed ID: 25825285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting.
    Leung M; Cheung C; Yu K; Yip B; Sham P; Li Q; Chua S; McAlonan G
    Schizophr Bull; 2011 Jan; 37(1):199-211. PubMed ID: 19759093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shared gray matter alterations in subtypes of addiction: a voxel-wise meta-analysis.
    Zhang M; Gao X; Yang Z; Wen M; Huang H; Zheng R; Wang W; Wei Y; Cheng J; Han S; Zhang Y
    Psychopharmacology (Berl); 2021 Sep; 238(9):2365-2379. PubMed ID: 34313804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of cerebral deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized voxel-based morphometry and resting state functional connectivity study.
    Lui S; Deng W; Huang X; Jiang L; Ma X; Chen H; Zhang T; Li X; Li D; Zou L; Tang H; Zhou XJ; Mechelli A; Collier DA; Sweeney JA; Li T; Gong Q
    Am J Psychiatry; 2009 Feb; 166(2):196-205. PubMed ID: 18981063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortical and Subcortical Gray Matter Volume in Youths With Conduct Problems: A Meta-analysis.
    Rogers JC; De Brito SA
    JAMA Psychiatry; 2016 Jan; 73(1):64-72. PubMed ID: 26650724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of structural and functional brain abnormalities in schizophrenia with persistent negative symptoms using activation likelihood estimation.
    Zhu T; Wang Z; Zhou C; Fang X; Huang C; Xie C; Ge H; Yan Z; Zhang X; Chen J
    Front Psychiatry; 2022; 13():957685. PubMed ID: 36238945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of regional brain volume change in schizophrenia associated with short-term atypical antipsychotic treatment.
    McClure RK; Carew K; Greeter S; Maushauer E; Steen G; Weinberger DR
    Schizophr Res; 2008 Jan; 98(1-3):29-39. PubMed ID: 17976957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain morphometry of individuals with schizophrenia with and without antipsychotic medication – The Northern Finland Birth Cohort 1966 Study.
    Moilanen J; Huhtaniska S; Haapea M; Jääskeläinen E; Veijola J; Isohanni M; Koponen H; Miettunen J
    Eur Psychiatry; 2015 Jul; 30(5):598-605. PubMed ID: 25791180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between structural and functional brain alterations in drug-free patients with schizophrenia: a multimodal meta-analysis.
    Gao X; Zhang W; Yao L; Xiao Y; Liu L; Liu J; Li S; Tao B; Shah C; Gong Q; Sweeney JA; Lui S
    J Psychiatry Neurosci; 2018 Mar; 43(2):131-142. PubMed ID: 29481320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.